'Plug-and-play' CAR T technology adapts as cancer changes

Дата публикации: 22-09-2026 14:20:13

Researchers from City of Hope have developed a new "plug-and-play" technology that adds engineered molecules to chimeric antigen receptor (CAR) T cells after treatment, allowing scientists to better control the cells and redirect them to attack different types of cancer. Published in Cancer Immunology Research, the preclinical study offers a more flexible way to help CAR T cells keep pace with mutating tumors.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Metabolic activity of gut bacteria can either promote or inhibit function of CAR T cells in cancer therapy	0	6.96	28-09-2026
2	Computer-designed T-cell receptors boost attacks on cancer and viral targets in early tests	0	11.68	23-09-2026
3	Cancer biologists bring in the B-cell reinforcements for immunotherapy	0	8.93	17-09-2026
4	A blood-based approach could enable personalized immunotherapy without the need for a tumor biopsy	0	10.91	29-09-2026
5	Making invisible cancers visible: A new route to turn 'cold' tumors 'hot'	0	7.83	17-09-2026
6	Activated donor immune cells may prevent severe complication after allogeneic stem cell transplantation	0	8.94	20-09-2026
7	Engineered 'triple-threat' immune cells could fight plaque buildup that causes heart attacks and strokes	0	6.75	22-09-2026
8	Study identifies potential RAS inhibitor-immunotherapy strategy for pancreatic cancer	0	7.48	23-09-2026
9	New potential for Crohn’s treatment	0	7.95	11-09-2026
10	Boosted Bacille Calmette-Guérin vaccine strategy significantly reduces tuberculosis relapse, scientists find	0	9.58	17-09-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8.18. Источник: medicalxpress.com.